Literature DB >> 30343319

The master regulator FUBP1: its emerging role in normal cell function and malignant development.

Lydie Debaize1, Marie-Bérengère Troadec2,3,4.   

Abstract

The human Far Upstream Element (FUSE) Binding Protein 1 (FUBP1) is a multifunctional DNA- and RNA-binding protein involved in diverse cellular processes. FUBP1 is a master regulator of transcription, translation, and RNA splicing. FUBP1 has been identified as a potent pro-proliferative and anti-apoptotic factor by modulation of complex networks. FUBP1 is also described either as an oncoprotein or a tumor suppressor. Especially, FUBP1 overexpression is observed in a growing number of cancer and leads to a deregulation of targets that includes the fine-tuned MYC oncogene. Moreover, recent loss-of-function analyses of FUBP1 establish its essential functions in hematopoietic stem cell maintenance and survival. Therefore, FUBP1 appears as an emerging suspect in hematologic disorders in addition to solid tumors. The scope of the present review is to describe the advances in our understanding of the molecular basis of FUBP1 functions in normal cells and carcinogenesis. We also delineate the recent progresses in the understanding of the master role of FUBP1 in normal and pathological hematopoiesis. We conclude that FUBP1 is not only worth studying biologically but is also of clinical relevance through its pivotal role in regulating multiple cellular processes and its involvement in oncogenesis.

Entities:  

Keywords:  FIR; KH domain; Leukemia; P21; P53; c-KIT

Mesh:

Substances:

Year:  2018        PMID: 30343319     DOI: 10.1007/s00018-018-2933-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  168 in total

1.  Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression.

Authors:  L He; J Liu; I Collins; S Sanford; B O'Connell; C J Benham; D Levens
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  Transient excess of MYC activity can elicit genomic instability and tumorigenesis.

Authors:  D W Felsher; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  The FBP interacting repressor targets TFIIH to inhibit activated transcription.

Authors:  J Liu; L He; I Collins; H Ge; D Libutti; J Li; J M Egly; D Levens
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

4.  The survival motor neuron protein interacts with the transactivator FUSE binding protein from human fetal brain.

Authors:  B Y Williams; S L Hamilton; H K Sarkar
Journal:  FEBS Lett       Date:  2000-03-24       Impact factor: 4.124

5.  Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization.

Authors:  D B Zimonjic; C L Keck; S S Thorgeirsson; N C Popescu
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

Review 6.  Hepatitis C viral RNA: challenges and promises.

Authors:  S T Shi; M M Lai
Journal:  Cell Mol Life Sci       Date:  2001-08       Impact factor: 9.261

7.  Modulation of P-element pre-mRNA splicing by a direct interaction between PSI and U1 snRNP 70K protein.

Authors:  E Labourier; M D Adams; D C Rio
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

8.  Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression.

Authors:  S Kawate; T Fukusato; S Ohwada; A Watanuki; Y Morishita
Journal:  Oncology       Date:  1999       Impact factor: 2.935

9.  Structure and dynamics of KH domains from FBP bound to single-stranded DNA.

Authors:  Demetrios T Braddock; John M Louis; James L Baber; David Levens; G Marius Clore
Journal:  Nature       Date:  2002-02-28       Impact factor: 49.962

Review 10.  Functions of the MDM2 oncoprotein.

Authors:  D A Freedman; L Wu; A J Levine
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

View more
  22 in total

1.  Regulation of the p53 expression profile by hnRNP K under stress conditions.

Authors:  Agata Swiatkowska; Mariola Dutkiewicz; Piotr Machtel; Damian M Janecki; Martyna Kabacinska; Paulina Żydowicz-Machtel; Jerzy Ciesiołka
Journal:  RNA Biol       Date:  2020-05-29       Impact factor: 4.652

2.  KHSRP loss increases neuronal growth and synaptic transmission and alters memory consolidation through RNA stabilization.

Authors:  Sarah L Olguin; Priyanka Patel; Courtney N Buchanan; Michela Dell'Orco; Amy S Gardiner; Robert Cole; Lauren S Vaughn; Anitha Sundararajan; Joann Mudge; Andrea M Allan; Pavel Ortinski; Jonathan L Brigman; Jeffery L Twiss; Nora I Perrone-Bizzozero
Journal:  Commun Biol       Date:  2022-07-07

Review 3.  RNA-binding proteins and their role in kidney disease.

Authors:  Michael Ignarski; Roman-Ulrich Müller; Lisa Seufert; Thomas Benzing
Journal:  Nat Rev Nephrol       Date:  2021-11-03       Impact factor: 42.439

Review 4.  Small molecule recognition of disease-relevant RNA structures.

Authors:  Samantha M Meyer; Christopher C Williams; Yoshihiro Akahori; Toru Tanaka; Haruo Aikawa; Yuquan Tong; Jessica L Childs-Disney; Matthew D Disney
Journal:  Chem Soc Rev       Date:  2020-10-05       Impact factor: 54.564

5.  dSPRINT: predicting DNA, RNA, ion, peptide and small molecule interaction sites within protein domains.

Authors:  Anat Etzion-Fuchs; David A Todd; Mona Singh
Journal:  Nucleic Acids Res       Date:  2021-07-21       Impact factor: 16.971

6.  High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity.

Authors:  Wei Liu; Xifeng Xiong; Weiguang Chen; Xiaojian Li; Xing Hua; Zhihe Liu; Zhi Zhang
Journal:  Int J Oncol       Date:  2020-06-10       Impact factor: 5.650

7.  Long non-coding RNA small nucleolar RNA host gene 6 aggravates pancreatic cancer through upregulation of far upstream element binding protein 1 by sponging microRNA-26a-5p.

Authors:  Xing-Xing Zhang; Hua Chen; Hui-Ying Li; Rui Chen; Lei He; Juan-Li Yang; Lin-Lin Xiao; Jin-Lian Chen
Journal:  Chin Med J (Engl)       Date:  2020-05-20       Impact factor: 2.628

8.  LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.

Authors:  Xinyi Qian; Juze Yang; Qiongzi Qiu; Xufan Li; Chengxi Jiang; Jia Li; Liangliang Dong; Kejing Ying; Bingjian Lu; Enguo Chen; Pengyuan Liu; Yan Lu
Journal:  J Hematol Oncol       Date:  2021-07-17       Impact factor: 17.388

9.  The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC.

Authors:  Xiaosong Wang; Lei Xing; Rui Yang; Hang Chen; Min Wang; Rong Jiang; Luyu Zhang; Junxia Chen
Journal:  Mol Cancer       Date:  2021-06-11       Impact factor: 27.401

10.  Multiple Functions of Fubp1 in Cell Cycle Progression and Cell Survival.

Authors:  Mingyu Kang; Hyeon Ji Kim; Tae-Jun Kim; Jin-Seok Byun; Jae-Ho Lee; Deok Heon Lee; Wanil Kim; Do-Yeon Kim
Journal:  Cells       Date:  2020-05-28       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.